| 1 |
吴兆苏, 姚崇华, 赵冬. 我国人群脑卒中发病率、死亡率的流行病学研究[J]. 中华流行病学杂志, 2003,24(3): 236-239.
|
| 2 |
Liu M, Wu B, Wang WZ, et al. Stroke in China: epidemiology,prevention, and management strategies [J]. Lancet Neurol, 2007,6 (5): 456-464.
|
| 3 |
Weening JJ, Remuzzi G. Exciting times for renal medicine [J].Lancet, 2010, 375 (9722): 1227-1228.
|
| 4 |
Kirby T. Screening for chronic kidney disease shows promise [J].Lancet, 2010, 375 (9722): 1240-1241.
|
| 5 |
Goldsmith D. The case against routine screening for vascular calcification in chronic kidney disease [J]. Semin Dial, 2010, 23(3): 280-282.
|
| 6 |
Monk RD, Bennett DA. Reno-cerebrovascular disease? The incognito kidney in cognition and stroke [J]. Neurology, 2006, 67(2): 196-198.
|
| 7 |
Lee M, Ovbiagele B. Reno-cerebrovascular disease: linking the nephron and neuron [J]. Expert Rev Neurother, 2011, 11(2):241-249.
|
| 8 |
Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation,classification, and stratification [J]. Ann Intern Med, 2003, 139(2): 137-147.
|
| 9 |
Lamb EJ, Levey AS, Stevens PE. The Kidney Disease Improving Global Outcomes (KDIGO) guideline update for chronic kidney disease: evolution not revolution [J]. Clin Chem, 2013, 59 (3):462-465.
|
| 10 |
Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [J]. N Engl J Med, 2004, 351 (13): 1296-1305.
|
| 11 |
Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD [J]. Am J Kidney Dis, 2014, 63 (5):713-735.
|
| 12 |
Lee M, Saver JL, Chang KH, et al. Low glomerular filtration rate and risk of stroke: meta-analysis [J]. BMJ, 2010, 341: c4249.
|
| 13 |
Li Z, Wang A, Cai J, et al. Impact of proteinuria and glomerular filtration rate on risk of ischaemic and intracerebral hemorrhagic stroke: a result from the Kailuan study. Eur J Neurol, 2015, 22(2): 355-360.
|
| 14 |
Turaj W, Slowik A, Wyrwicz-Petkow U, et al. The prognostic significance of microalbuminuria in non-diabetic acute stroke patients [J]. Med Sci Monit, 2001, 7 (5): 989-994.
|
| 15 |
Wang X, Luo Y, Wang Y, et al. Comparison of associations of outcomes after stroke with estimated GFR using Chinese modifications of the MDRD study and CKD-EPI creatinine equations: results from the China National Stroke Registry [J]. Am J Kidney Dis, 2014, 63(1): 59-67.
|
| 16 |
Terao Y, Takada M, Tanabe T, et al. Microalbuminuria is a prognostic predictor in aneurysmal subarachnoid hemorrhage [J].Intensive Care Med, 2007, 33(6): 1000-1006.
|
| 17 |
Ovbiagele B, Sanossian N, Liebeskind DS, et al. Indices of kidney dysfunction and discharge outcomes in hospitalized stroke patients without known renal disease [J]. Cerebrovasc Dis, 2009, 28(6):582-588.
|
| 18 |
Zhao L, Du W, Zhao X, et al. Favorable functional recovery in overweight ischemic stroke survivors: findings from the China National Stroke Registry [J]. J Stroke Cerebrovasc Dis, 2014, 23(3): e201-e206.
|
| 19 |
Wang X, Wang Y, Wang C, et al. Association between estimated glomerular filtration rate and clinical outcomes in patients with acute ischaemic stroke: results from China National Stroke Registry [J].Age Ageing, 2014, 43(6): 839-845.
|
| 20 |
Luo Y, Wang X, Wang Y, et al. Association of glomerular filtration rate with outcomes of acute stroke in type 2 diabetic patients: results from the china national stroke registry [J]. Diabetes Care, 2014,37(1): 173-179.
|
| 21 |
Luo Y, Wang X, Matsushita K, et al. Associations between estimated glomerular filtration rate and stroke outcomes in diabetic versus non-diabetic patients [J]. Stroke, 2014, 45 (10):2887-2893.
|
| 22 |
O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy [J]. Hypertension, 2005, 46 (1): 200-204.
|
| 23 |
Endemann DH, Schiffrin EL. Endothelial dysfunction [J]. J Am Soc Nephrol, 2004, 15 (8): 1983-1992.
|
| 24 |
Locatelli F, Bommer J, London GM, et al. Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment [J]. Nephrol Dial Transplant, 2001, 16 (3): 459-468.
|
| 25 |
Bikkina M, Levy D, Evans JC, et al. Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study [J].JAMA, 1994, 272 (1): 33-36.
|
| 26 |
Stehouwer CD, Smulders YM. Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms [J]. J Am Soc Nephrol, 2006, 17 (8): 2106-2111.
|
| 27 |
Vaziri ND, Dicus M, Ho ND, et al. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency [J]. Kidney Int, 2003, 63 (1): 179-185.
|
| 28 |
Al-Rawi MB, Aleisa AM, Khattab MM. Superoxide anion stress attenuates the contractile response of the Guinea pig vas deferens to ATP and diadenosine tetraphosphate. Possible effect on calcium dysregulation [J]. Pharmacology, 2008, 82 (2):142-147.
|
| 29 |
Vaziri ND, Dicus M, Ho ND, et al. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency [J]. Kidney Int, 2003, 63 (1): 179-185.
|
| 30 |
Himmelfarb J, Tuttle KR. Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease [J]. N Engl J Med, 2014,370 (18): 1768-1769.
|
| 31 |
Pergola PE, Raskin P, Toto RD, et al. Bardoxolone methyl and kidney function in CKD with type 2 diabetes [J]. N Engl J Med,2011,365 (4): 327-336.
|
| 32 |
de Zeeuw D, Akizawa T, Audhya P, et al. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease [J]. N Engl J Med, 2013, 369 (26): 2492-2503.
|